Skip to main content
Article thumbnail
Location of Repository

Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors

By B.Y. Ahmed, S. Chakravarthy, R. Eggers, W.T. Hermens, J.Y. Zhang, S.P. Niclou, C. Levelt, F. Sablitzky, P.N. Anderson, A. Lieberman and J. Verhaagen

Abstract

BACKGROUND: Inactivating genes in vivo is an important technique for establishing their function in the adult nervous system. Unfortunately, conventional knockout mice may suffer from several limitations including embryonic or perinatal lethality and the compensatory regulation of other genes. One approach to producing conditional activation or inactivation of genes involves the use of Cre recombinase to remove loxP-flanked segments of DNA. We have studied the effects of delivering Cre to the hippocampus and neocortex of adult mice by injecting replication-deficient adeno-associated virus (AAV) and lentiviral (LV) vectors into discrete regions of the forebrain. RESULTS: Recombinant AAV-Cre, AAV-GFP (green fluorescent protein) and LV-Cre-EGFP (enhanced GFP) were made with the transgene controlled by the cytomegalovirus promoter. Infecting 293T cells in vitro with AAV-Cre and LV-Cre-EGFP resulted in transduction of most cells as shown by GFP fluorescence and Cre immunoreactivity. Injections of submicrolitre quantities of LV-Cre-EGFP and mixtures of AAV-Cre with AAV-GFP into the neocortex and hippocampus of adult Rosa26 reporter mice resulted in strong Cre and GFP expression in the dentate gyrus and moderate to strong labelling in specific regions of the hippocampus and in the neocortex, mainly in neurons. The pattern of expression of Cre and GFP obtained with AAV and LV vectors was very similar. X-gal staining showed that Cre-mediated recombination had occurred in neurons in the same regions of the brain, starting at 3 days post-injection. No obvious toxic effects of Cre expression were detected even after four weeks post-injection. CONCLUSION: AAV and LV vectors are capable of delivering Cre to neurons in discrete regions of the adult mouse brain and producing recombinatio

Year: 2004
OAI identifier: oai:eprints.nottingham.ac.uk:114
Provided by: Nottingham ePrints

Suggested articles

Citations

  1. (1999). Adeno-associated viral vectors for gene transfer and gene therapy. Biol Chem
  2. (2001). Alt FW: Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity doi
  3. (2000). CL: Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system. doi
  4. (1994). Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science
  5. Delivery of the Cre recombinase by a self deleting lentiviral vector: Efficient gene targeting in vivo.
  6. (2001). DJ: Adenovirus-mediated Cre deletion of floxed sequences in primary mouse cells is an efficient alternative for studies of gene deletion. doi
  7. (2001). DM: Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell
  8. (1994). During MJ: Long-term gene expression and phenotyping correction using adeno-associated virus vectors in the mammalian brain. Nat Genet
  9. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA
  10. (2002). FH: Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc Natl Acad Sci USA
  11. (1997). FH: Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector.
  12. (1997). Gene transfer by adenoassociated virus vectors into the central nervous system. Exp Neurol
  13. (2000). Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet doi
  14. (2001). Growth inhibition and DNA damage Publish with BioMed Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime."
  15. (1981). Hoess R: Bacteriophage P1 site-specific recombination. II. Recombination between loxP and the bacterial chromosome.
  16. (2000). Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids.
  17. (1993). Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell
  18. (1994). Karpati GA: Differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet doi
  19. (2001). KBJ: Atlas of Mouse brain, 2nd edition.
  20. (2002). Lentiviral transduction of green fluorescent protein in retinal epithelium: evidence of rejection. Vision Res doi
  21. (1998). Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol
  22. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther doi
  23. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of doi
  24. (1993). Rajewsky K: Generation of a mouse strain that produces immunoglobulin kappa chains with human constant regions. Science
  25. (1996). RJ: Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res
  26. (2003). RW: Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector.
  27. (2001). Sablitzky F: Cre-mediated transgene activation in the developing and adult mouse brain. Genesis
  28. (1999). Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle.
  29. (1983). Studies on the properties of P1 site-specific recombination: Evidence for the topologically unlinked products following recombination. Cell
  30. (1997). Targeted gene disruption: applications in neurobiology.
  31. (1992). Targeted oncogene activation by site-specific recombination in transgenic mice.
  32. (1996). Tonegawa S: Subregion- and cell type restricted gene knockout in mouse brain. Cell
  33. (1996). Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science
  34. (1998). Trono D: Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.
  35. Vodjdani G: Targeting conditional gene modification into the serotonin neurons of the dorsal raphe nucleus by viral delivery of the Cre recombinase. Mol Cell Neurosci

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.